Please enable JavaScript to continue using this application.

Compare $INO vs $PMVP | Chartloom

Compare

$INO vs $PMVP

Inovio Pharmaceuticals Inc · PMV Pharmaceuticals Inc

INO

Inovio Pharmaceuticals Inc

PMVP

PMV Pharmaceuticals Inc

Compare $INO vs $PMVP

Comparing Inovio Pharmaceuticals Inc and PMV Pharmaceuticals Inc

INOInovio Pharmaceuticals Inc

PMVPPMV Pharmaceuticals Inc

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

PMVPPMV Pharmaceuticals Inc

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.6%

52W performance

7.0%

FCF yield

-87.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INO

PMVP

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

INO$95M

PMVP$81M

Enterprise Value

INO$63M

PMVP$69M

Price

INO$1.15

PMVP$1.52

P/E Ratio

INON/A

PMVPN/A

P/S Ratio

INO423.69x

PMVP0.00x

EV/Sales

INO312.32x

PMVP0.00x

EV/EBITDA

INO0.00x

PMVP0.00x

P/B Ratio

INO27.44x

PMVP1.89x

P/FCF Ratio

INON/A

PMVPN/A

EV/FCF

INO-0.78x

PMVP-0.96x

PEG Ratio

INON/A

PMVPN/A

Forward P/E (NTM)

INON/A

PMVPN/A

Forward P/S (NTM)

INO2.48x

PMVPN/A

Revenue (TTM)

INO$0

PMVP$0

Revenue Growth (YoY)

INO-100.0%

PMVPN/A

Forward Rev Growth

INO7491.0%

PMVP546.2%

Gross Margin (TTM)

INO58.9%

PMVP0.0%

Operating Margin (TTM)

INO0.0%

PMVP0.0%

EBITDA Margin (TTM)

INO0.0%

PMVP0.0%

Net Margin (TTM)

INO0.0%

PMVP0.0%

FCF Margin (TTM)

INON/A

PMVPN/A

Net Income (TTM)

INO$-67M

PMVP$-75M

FCF (TTM)

INO$-81M

PMVP$-71M

EPS (TTM)

INO-$0.83

PMVP-$1.41

ROE (TTM)

INO-19050.0%

PMVP-7811.0%

ROA (TTM)

INO-11105.0%

PMVP-7013.0%

ROIC (TTM)

INO-19050.0%

PMVP-7811.0%

Cash

INO$32M

PMVP$12M

Debt

INO$0

PMVP$0

Net Cash/Debt

INO$32M

PMVP$12M

Current Ratio (TTM)

INO1.00x

PMVP7.70x

Quick Ratio (TTM)

INO0.92x

PMVP7.52x

Debt/Equity (TTM)

INO0.00x

PMVP0.00x

Debt/Assets (TTM)

INO0.0%

PMVP0.0%

Interest Coverage (TTM)

INON/A

PMVPN/A

Net Debt/EBITDA (TTM)

INO0.00x

PMVP0.00x

Beta

INO1.68

PMVP1.48

52W Performance

INO-55.1%

PMVP7.0%

YTD Performance

INO-32.0%

PMVP23.6%

% from 52W High

INO-57.7%

PMVP-20.4%

% from 52W Low

INO104.2%

PMVP49.0%

Asset Turnover (TTM)

INO0.00x

PMVP0.00x

FCF Yield (TTM)

INO-85.4%

PMVP-87.9%

Earnings Yield (TTM)

INO-71.3%

PMVP-92.8%

Dividend Yield (TTM)

INON/A

PMVPN/A

Rule of 40

INO-100.0

PMVP0.0

EV/GP/RG

INON/A

PMVPN/A

Ticker research

View INO research View PMVP research

Metric	INO Inovio Pharmaceuticals Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$95M	$81M
Enterprise Value	$63M	$69M
Price	$1.15	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	0.00x
EV/Sales	312.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	7491.0%	546.2%
Profitability
Gross Margin (TTM)	58.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-67M	$-75M
FCF (TTM)	$-81M	$-71M
EPS (TTM)	-$0.83	-$1.41
ROE (TTM)	-19050.0%	-7811.0%
ROA (TTM)	-11105.0%	-7013.0%
ROIC (TTM)	-19050.0%	-7811.0%
Financial Health
Cash	$32M	$12M
Debt	$0	$0
Net Cash/Debt	$32M	$12M
Current Ratio (TTM)	1.00x	7.70x
Quick Ratio (TTM)	0.92x	7.52x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.48
52W Performance	-55.1%	7.0%
YTD Performance	-32.0%	23.6%
% from 52W High	-57.7%	-20.4%
% from 52W Low	104.2%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-85.4%	-87.9%
Earnings Yield (TTM)	-71.3%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View PMVP research

Valuation

P/S Ratio

PMVP

0.00x

INO

423.69x

EV/FCF

PMVP

-0.96x

INO

-0.78x

Growth & revenue

Revenue Growth TTM

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

PMVP

546.2%

Profitability & performance

Gross Margin

INO

58.9%

PMVP

0.0%

ROE

PMVP

-7811.0%

INO

-19050.0%

FCF Yield %

INO

-85.4%

PMVP

-87.9%

52-Week Performance

PMVP

7.0%

INO

-55.1%

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

INO$95M

PMVP$81M

Enterprise Value

INO$63M

PMVP$69M

Price

INO$1.15

PMVP$1.52

P/E Ratio

INON/A

PMVPN/A

P/S Ratio

INO423.69x

PMVP0.00x

EV/Sales

INO312.32x

PMVP0.00x

EV/EBITDA

INO0.00x

PMVP0.00x

P/B Ratio

INO27.44x

PMVP1.89x

P/FCF Ratio

INON/A

PMVPN/A

EV/FCF

INO-0.78x

PMVP-0.96x

PEG Ratio

INON/A

PMVPN/A

Forward P/E (NTM)

INON/A

PMVPN/A

Forward P/S (NTM)

INO2.48x

PMVPN/A

Revenue (TTM)

INO$0

PMVP$0

Revenue Growth (YoY)

INO-100.0%

PMVPN/A

Forward Rev Growth

INO7491.0%

PMVP546.2%

Gross Margin (TTM)

INO58.9%

PMVP0.0%

Operating Margin (TTM)

INO0.0%

PMVP0.0%

EBITDA Margin (TTM)

INO0.0%

PMVP0.0%

Net Margin (TTM)

INO0.0%

PMVP0.0%

FCF Margin (TTM)

INON/A

PMVPN/A

Net Income (TTM)

INO$-67M

PMVP$-75M

FCF (TTM)

INO$-81M

PMVP$-71M

EPS (TTM)

INO-$0.83

PMVP-$1.41

ROE (TTM)

INO-19050.0%

PMVP-7811.0%

ROA (TTM)

INO-11105.0%

PMVP-7013.0%

ROIC (TTM)

INO-19050.0%

PMVP-7811.0%

Cash

INO$32M

PMVP$12M

Debt

INO$0

PMVP$0

Net Cash/Debt

INO$32M

PMVP$12M

Current Ratio (TTM)

INO1.00x

PMVP7.70x

Quick Ratio (TTM)

INO0.92x

PMVP7.52x

Debt/Equity (TTM)

INO0.00x

PMVP0.00x

Debt/Assets (TTM)

INO0.0%

PMVP0.0%

Interest Coverage (TTM)

INON/A

PMVPN/A

Net Debt/EBITDA (TTM)

INO0.00x

PMVP0.00x

Beta

INO1.68

PMVP1.48

52W Performance

INO-55.1%

PMVP7.0%

YTD Performance

INO-32.0%

PMVP23.6%

% from 52W High

INO-57.7%

PMVP-20.4%

% from 52W Low

INO104.2%

PMVP49.0%

Asset Turnover (TTM)

INO0.00x

PMVP0.00x

FCF Yield (TTM)

INO-85.4%

PMVP-87.9%

Earnings Yield (TTM)

INO-71.3%

PMVP-92.8%

Dividend Yield (TTM)

INON/A

PMVPN/A

Rule of 40

INO-100.0

PMVP0.0

EV/GP/RG

INON/A

PMVPN/A

Ticker research

View INO research View PMVP research

Metric	INO Inovio Pharmaceuticals Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$95M	$81M
Enterprise Value	$63M	$69M
Price	$1.15	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	0.00x
EV/Sales	312.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	7491.0%	546.2%
Profitability
Gross Margin (TTM)	58.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-67M	$-75M
FCF (TTM)	$-81M	$-71M
EPS (TTM)	-$0.83	-$1.41
ROE (TTM)	-19050.0%	-7811.0%
ROA (TTM)	-11105.0%	-7013.0%
ROIC (TTM)	-19050.0%	-7811.0%
Financial Health
Cash	$32M	$12M
Debt	$0	$0
Net Cash/Debt	$32M	$12M
Current Ratio (TTM)	1.00x	7.70x
Quick Ratio (TTM)	0.92x	7.52x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.48
52W Performance	-55.1%	7.0%
YTD Performance	-32.0%	23.6%
% from 52W High	-57.7%	-20.4%
% from 52W Low	104.2%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-85.4%	-87.9%
Earnings Yield (TTM)	-71.3%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View PMVP research